Latest Immunotransplant Stories
Researchers at MIT have found success by combining two branches of the immune system to work fighting cancer.
OXFORD, England, April 8, 2015 /PRNewswire/ -- ~ A Phase I/IIa study of IMCgp100: partial and complete durable responses with a novel first-in-class
Cancer vaccines prime the immune system to attack cancer cells, decreasing tumor progression.
Those suffering from Melanoma may have new hope. A recent study shows that a patient's own cells may reduce advanced melanoma and send the cancer into remission.
Like brainy bookworms unprepared for the rough and tumble of post-graduation life, white blood cells trained by scientists to attack tumors tend to fade away quickly when injected into cancer patients.
CAMBRIDGE, Mass., Dec.
A new process for creating a personalized vaccine may become a crucial tool in helping patients with colorectal cancer develop an immune response against their own tumors.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.